Abstract
In spite of the fact that cadaveric donor transplantion carries a rare risk of transferring malignancy to the recipient, it is a serious complication that should be taken into consideration (1-3). In immunocompetent individuals, the possibility of tumor transmission is quite low. However, immunosupression which is required in transplantation increases the risk of tumor transfer between donor and recipient significantly (4,5). It is of vital importance to perform the necessary investigations for malignancy in living or cadaveric donors prior to organ transplantation.
License
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Article Type: Brief Report
EUR J GEN MED, Volume 5, Issue 4, October 2008, 254-255
https://doi.org/10.29333/ejgm/82619
Publication date: 15 Oct 2008
Article Views: 1149
Article Downloads: 1466
Open Access References How to cite this article